#decarbonization #India #Mumbai #Sustainability Report #Piramal Pharma

Piramal Pharma's FY 2025 Sustainability Report

Piramal Pharma Limited (PPL), a renowned global player in the pharmaceutical industry, recently unveiled its fourth annual sustainability report for the fiscal year 2025, themed "Responsible Innovation for Sustainable Growth." This comprehensive report underscores PPL's measurable advancements and its reinforced commitment under four strategic pillars:

1. Business Resilience
2. Quality and Excellence
3. Responsible Operations
4. Stakeholder Orientation

Corporate Commitment to Sustainability

The aim is clear: PPL aspires to create a positive impact while achieving success through scientifically-backed innovations and ethical responsibilities. The sustainability report reflects how PPL is embedding responsible practices throughout its global operations. This encompasses everything from enhancing governance and ethical standards to accelerating climate action and promoting diversity and inclusion. Moreover, the company's commitment has been validated through an external verification by DNV.

Highlights of Business Resilience

Recent initiatives have led to significant strides in PPL’s governance, including:

• - 50% of the board members being independent, with 30% representation of women, surpassing regulatory requirements.
• - Maintaining a flawless record with zero data breaches and 100% compliance in code of conduct training.
• - Evaluating 26.5% of critical suppliers based on sustainability criteria and building capacities of 30% of them by FY 2026.

Quality and Excellence

Reflecting its dedication to quality, PPL has completed 36 successful regulatory inspections, including two from the US FDA, and has conducted 165 customer audits globally. PPL continues to enhance its digital infrastructure, maintaining an impressive customer satisfaction score of 85% in CDMO/PPS services and 87% in Critical Care/PCC segments.

Responsible Operations: Decarbonization Milestones

PPL is making tangible progress in reducing its environmental footprint:

• - Achieving a 6% reduction in Scope 1 and 2 emissions year-over-year.
• - Demonstrating a 7.8% increase in renewable energy usage, with 20.2% of total energy derived from bioenergy sources.
• - Aiming for a 90% recycling rate for non-hazardous waste and achieving zero disposal of hazardous waste.
• - Conserving 210,000 kiloliters of fresh water through efficient water management practices.
• - Initiating biodiversity conservation projects, which include planting over 2,000 saplings and maintaining a 30% green space across all facilities in India.
• - Transitioning the coal-fired steam boiler at the PPL plant in Digwal, India, to operate on renewable biomass briquettes, a pivotal step in its sustainability journey.

Stakeholder Orientation: Diversity and Inclusion

PPL is striving for equity within its workforce:

• - With women making up 30% of board members, and a global workforce composition that includes 20% women, showing a 2.7% increase from the previous year.
• - 100% participation of employees in ESG training, alongside significant safety initiatives leading to a 45% reduction in the Lost Time Injury Rate (LTIR).

As Nandini Piramal, Chairperson of PPL, noted, "Sustainability is not just a responsibility but a conscious choice that shapes our operations and growth. In today's complex environment marked by climate change and rising ethical expectations, sustainability has become pivotal for long-term value creation. We continue to push forward our decarbonization efforts and our commitment to diversity, equity, and inclusion, fostering a culture that is inclusive and impactful on both our communities and the environment."

Community Engagement and CSR Initiatives

In FY 2025, PPL has also advanced its Corporate Social Responsibility (CSR) initiatives, collaborating with the Piramal Foundation in 112 underserved districts across India. The focus areas include education, community well-being, and women's empowerment. Investments of INR 53.4 million have been directed towards enhancing school infrastructure and teaching capabilities, addressing public health, and ensuring safe drinking water.

Moreover, employee participation through volunteer activities, such as tree-planting campaigns and health drives, has amplified the impact of these initiatives. Collaborating with the Life Sciences Sector Skill Development Council, PPL has launched a women-led training program near its Digwal site, and continues to support the Aspirational Bharat Collaborative (ABC), aiming to uplift 100 million lives in underserved regions by 2047.

Conclusion

The sustainability report adheres to GRI guidelines and reflects PPL's commitment to responsible growth and effective stakeholder engagement. For more details, the full report is available here.

Piramal Pharma Limited (PPL) operates 17 global development and manufacturing sites, providing a diverse portfolio of products and services spanning over 100 countries. This includes integrated contract development and manufacturing services through Piramal Pharma Solutions (PPS) and complex hospital generics under Piramal Critical Care (PCC). Additionally, PPL maintains a strategic minority stake in Yapan Bio Private Limited, focusing on biologics and vaccines.